Tower Research Capital LLC (Trc) Renovo Rx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,683 shares of RNXT stock, worth $4,051. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,683
Previous 817
350.8%
Holding current value
$4,051
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RNXT
# of Institutions
28Shares Held
11.3MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$3.81 Million2.59% of portfolio
-
Awm Investment Company, Inc. New York, NY2.29MShares$2.51 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.83 Million0.0% of portfolio
-
Bank Of The West975KShares$1.07 Million0.27% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL689KShares$757,4340.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.97M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...